Related Experiment Video
Updated: May 10, 2026

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
The canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma
Chengjun Li1, Xin Shi, Guangxin Zhou
1Jinling Hospital, Department of Orthopedics, Nanjing University, School of Medicine, Nanjing 210002, Peoples R China.
Abstract:
The canonical Wnt-beta -catenin signaling pathway is a key component of normal skeletal development and disease. Alterations within this signaling pathway have been described in human and canine osteosarcoma (OS); however, debate exists as to whether or not alterations in this pathway contribute to OS development in humans. In metastatic OS, the Wnt-β-catenin pathway promotes the invasion and migration of OS cells and β-catenin acts as a biological marker of OS with the potential to metastasize to the lung. The participation of the Wnt-β-catenin pathway in OS development and metastasis is regulated by several factors, including hormones and alkaline phosphatase (ALP). This pathway is also involved in the resistance of OS to chemotherapy, especially in resistance to all three drugs used in standard chemotherapy, i.e. doxorubicin, cisplatin and methotrexate (MTX). In this review, we will summarize recent findings regarding the Wnt-β-catenin pathway in OS development and chemotherapy.
Insights
The Wnt-beta-catenin pathway is crucial in osteosarcoma (OS) development and metastasis. This review explores its role in OS progression and chemotherapy resistance.
Area of Science:
- Oncology
- Molecular Biology
- Skeletal Development
Background:
- The Wnt-beta-catenin signaling pathway is vital for skeletal development.
- Dysregulation of this pathway is implicated in human and canine osteosarcoma (OS).
- Its precise role in human OS development remains debated.
Purpose of the Study:
- To review recent findings on the Wnt-beta-catenin pathway in osteosarcoma.
- To examine the pathway's involvement in OS development and metastasis.
- To discuss its role in chemotherapy resistance.
Main Methods:
- Literature review of recent studies on the Wnt-beta-catenin pathway in osteosarcoma.
- Analysis of the pathway's regulation by hormones and alkaline phosphatase (ALP).
- Examination of the pathway's influence on OS cell invasion, migration, and drug resistance.
Main Results:
- The Wnt-beta-catenin pathway promotes invasion and migration in metastatic OS.
- Beta-catenin serves as a marker for lung metastasis potential in OS.
- The pathway is implicated in resistance to doxorubicin, cisplatin, and methotrexate (MTX).
Conclusions:
- The Wnt-beta-catenin pathway significantly impacts osteosarcoma progression and metastasis.
- Understanding this pathway is key to developing new therapeutic strategies for OS.
- The pathway's role in chemotherapy resistance highlights potential targets for overcoming treatment failure.
Related Concept Videos
Canonical Wnt Signaling Pathway
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Non-Canonical Wnt Signaling Pathways
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
